KPMA discusses damages of drug price cutback

The Korea Pharmaceutical Manufacturers Association plans to assess the damage that the government's unilateral measures to reduce drug prices would cause in domestic pharmaceutical industry in the future and map out proper countermeasures.

The KPMA said the government should also produce policies that could heighten the competitive power of local drug makers, so that they could turn the cris...